P Ojeda-Walczuk

Centro Nacional de Investigaciones Oncológicas

Screening of epigenetic modulators in Ewing's Sarcoma using CRISPR/Cas9

A Alonso-Yanez

Centro Nacional de Investigaciones Oncológicas

Generation of a dual-fluorescent reporter cell line to test different delivery approaches for the CRISPR/Cas system

B D Tomeo-Martín

Universidad Alfonso X El Sabio

Response to oncolytic virus in canine patients with spontaneous gliomas

B D Tomeo-Martín

Universidad Alfonso X El Sabio

Oncolytic virus as immunotherapy treatment in canine cancer patients

L Moya-Borrego

IDIBELL-ICO

Exploring the pore-forming toxin aerolysin as a candidate transgene for oncolytic adenoviruses

Y Jimenez Martinez 

Universidad de Granada

Suicide gene therapy: ldrB genes from E.coli as a potential tool against cancer

M Pulido

Centro de Cirugía de Mínima Invasión Jesús Usón

Secretome from porcine cardiosphered derived-cells decreased the pro-inflammatory profile of porcine M1 macrophages in vitro

M Pulido

Centro de Cirugía de Mínima Invasión Jesús Usón

Positive angiogenic effect of  secretome  from menstrual blood-derived mesenchymal stromal cells (MenSCs) on HUVECs

M Pulido

Centro de Cirugía de Mínima Invasión Jesús Usón

Proteomic profile on remote myocardium after administration of secretome from menstrual blood derived cells in swine infarct model

L de Lara-Peña

Universidad de Granada; Biopathology and Regenerative Medicine Institute (IBIMER); Biosanitary Investigation Institute (Ibs.GRANADA); Excellence Research Unit “Modelling Nature” (Mnat)

Bioengineered 3D models of pancreatic cancer as personalized medicine platforms

L Beltrán-Camacho

Universidad de Cádiz; Instituto de Investigación e Innovación Biomédica de Cádiz

Pre-stimulation of CACs with atherosclerotic factors potentiate their regenerative properties in critical limb ischemia

J López de Andrés

Universidad de Granada; Centro de Investigación Biomédica; Biosanitary Research Institute of Granada (ibs.GRANADA)

3D-Bioprinted CSC-based malignant melanoma models as a new tool for antitumoral drug screening